Unresectable Liposarcoma
6 clinical trials · Condition
◉ Watch Unresectable Liposarcoma
| Record | Firm | Date |
|---|---|---|
| Avelumab and Trabectedin in Treating Patients With Liposarcoma or Leiomyosarcoma That is Metastatic or Cannot Be Removed by Surgery (NCT03074318) | Fred Hutchinson Cancer Center | 2017-09-28 |
| Ribociclib and Doxorubicin in Treating Patients With Metastatic or Advanced Soft Tissue Sarcomas That Cannot Be Removed by Surgery (NCT03009201) | OHSU Knight Cancer Institute | 2017-03-10 |
| Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Sarcoma That Cannot Be Removed by Surgery (NCT02500797) | National Cancer Institute (NCI) | 2015-08-13 |
Track Unresectable Liposarcoma automatically
Every clearance here is in the API, with alerts when new ones post.